Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast

[News]

Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020.

More... (https://www.news-medical.net/news/20200522/Novel-biomarkers-linked-to-improved-outcomes-with-immunotherapy-in-metastatic-breast-cancer.aspx)